Cargando…

Combination radiation and immunotherapy in gynecologic malignancies—a comprehensive review

Definitive and adjuvant radiation and chemoradiation have been mainstays in the management of multiple gynecologic malignancies for decades. However, despite these treatments, the prognosis of patients with locally advanced, recurrent, refractory, and metastatic disease continues to be poor. Over th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladbury, Colton, Germino, Elizabeth, Novak, Jennifer, Liu, Jason, Horne, Zachary, Dyer, Brandon, Glaser, Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797685/ https://www.ncbi.nlm.nih.gov/pubmed/35116574 http://dx.doi.org/10.21037/tcr-20-3019

Ejemplares similares

Radiation and immunotherapy: united as one in the fight against cancer
por: Amini, Arya, et al.
Publicado: (2021)

Narrative review of immunotherapy and radiation therapy in elderly patients
por: Chau, Brittney, et al.
Publicado: (2021)

Immunotherapy and radiation for high-grade glioma: a narrative review
por: Fakhoury, Kareem R., et al.
Publicado: (2021)

A narrative review of combining radiation and immunotherapy in gastroesophageal cancers
por: Yoon, Kevin, et al.
Publicado: (2021)

The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review
por: Heinzerling, John H., et al.
Publicado: (2021)

Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review
por: Hayman, Thomas J., et al.
Publicado: (2021)

Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases
por: Moskalenko, Marina, et al.
Publicado: (2021)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension
por: Sung, Ki‐Chul, et al.
Publicado: (2023)

Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study
por: Lin, Junxiong, et al.
Publicado: (2023)

Age‐specific differences in hypertension combination management and associated factors influencing treatment choice
por: Xiong, Jianfei, et al.
Publicado: (2023)

Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
por: Rajeev-Kumar, Greeshma, et al.
Publicado: (2022)

A Clinical Evaluation of American Brachytherapy Society Consensus Guideline for Bulky Vaginal Mass in Gynecological Cancer
por: Murofushi, Keiko Nemoto, et al.
Publicado: (2018)

Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic review
por: Liu, Jason, et al.
Publicado: (2023)

245 Likelihood of live birth following fertility preserving treatment among reproductive-age women diagnosed with gynecologic malignancies or pre-malignancies
por: Yu, Ruoxi, et al.
Publicado: (2022)

Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: a joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statement
por: Alvarez, Ronald D., et al.
Publicado: (2020)

Toxicity of radiation and immunotherapy combinations
por: Verma, Vivek, et al.
Publicado: (2018)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

The DNA damage response in immunotherapy and radiation
por: Samstein, Robert M., et al.
Publicado: (2018)

Exploring optimal sequencing of radiation and immunotherapy combinations
por: Gunderson, Andrew J., et al.
Publicado: (2018)

Introduction to the special edition on immunotherapy and radiation oncology
por: Bornstein, Sophia, et al.
Publicado: (2018)

Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia
por: Ladbury, Colton, et al.
Publicado: (2021)

Stereotactic Radiosurgery in a Small Cell Lung Cancer Patient With Numerous Brain Metastases
por: Lian, Andrew, et al.
Publicado: (2022)

THER-07. INHIBITION OF THE RAS SIGNALING ENHANCES VIRAL ONCOLYSIS IN MALIGNANT GLIOMAS
por: Arakawa, Yoshiki, et al.
Publicado: (2020)

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3-mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia
por: Niswander, Lisa M., et al.
Publicado: (2022)

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial
por: Klein, Oliver, et al.
Publicado: (2021)

Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals
por: Funston, Garth, et al.
Publicado: (2018)

Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
por: Schmidt, Dayane, et al.
Publicado: (2022)

Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model
por: Wang, Jie, et al.
Publicado: (2022)

Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent international studies
por: Zhou, Jian-Guo, et al.
Publicado: (2023)

Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions
por: Kim, Yejin, et al.
Publicado: (2023)

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes
por: Tatovic, D, et al.
Publicado: (2022)

IMMU-02. Targeted innovative antibody fragment-based immunotherapy for medulloblastoma
por: Niesen, Judith, et al.
Publicado: (2022)

Monitoring the ecological status of rivers with diatom eDNA metabarcoding: A comparison of taxonomic markers and analytical approaches for the inference of a molecular diatom index
por: Apothéloz‐Perret‐Gentil, Laure, et al.
Publicado: (2020)

Ecosystems monitoring powered by environmental genomics: A review of current strategies with an implementation roadmap
por: Cordier, Tristan, et al.
Publicado: (2020)

IMMU-27. ANALYSIS OF IMMUNE SIGNATURES IN PEDIATRIC GLIOBLASTOMAS FOR PATIENT STRATIFICATION TO IMMUNOTHERAPY
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2020)

IMMU-15. PROTEOGENOMIC DISCOVERY OF NOVEL TUMOR PEPTIDES AS NEOANTIGENS FOR PERSONALIZED T CELL IMMUNOTHERAPY IN MEDULLOBLASTOMA
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2020)

IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-kB PATHWAYS
por: Marquardt, Viktoria, et al.
Publicado: (2020)

IMMU-16. INTRA-TUMOURAL IL-12 DELIVERY ENABLES CAR T-CELL IMMUNOTHERAPY FOR HIGH-GRADE GLIOMA
por: Agliardi, Giulia, et al.
Publicado: (2020)

IMMU-17. Comprehensive immunological gene expression profiling of pediatric brain tumors
por: Levine, Adrian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i3tg5mmt7ea9rqkdtfla3rqlla